OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Therapies for Diabetes
Roni Weinberg Sibony, Omri Segev, Saar Dor, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17147-17147
Open Access | Times Cited: 22

Showing 22 citing articles:

Multifunctional nanocomposites mediated novel hydrogel for diabetic wound repair
Yingjuan Zhou, Jiaxin Yang, Yan Li, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 13, pp. 3292-3306
Closed Access | Times Cited: 5

Nanostructure-Based Drug Delivery in Alleviating Type 2 Diabetes Mellitus
Annu Saini, Lokesh Nagar, Rohil Panwar, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access

Characterization and efficient screening of natural DPP-IV inhibitory peptides from Huizhou dry-cured ham: In Silico and In Vitro studies
Guosheng Xu, Feiran Xu, Tong Ji, et al.
Journal of Food Composition and Analysis (2025), pp. 107233-107233
Closed Access

Exploring the prevalence of gout among underrepresented low socioeconomic status type 2 diabetes populations
Jessica Smith, Abey Martin, Jane Mundadan, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access

Recent advances in pancreatic α-cell transdifferentiation for diabetes therapy
Yanjiao Li, Jinyu Zhu, Congyang Yue, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

De novo in silico screening of natural products for antidiabetic drug discovery: ADMET profiling, molecular docking, and molecular dynamics simulations
Sulyman Olalekan Ibrahim, Yusuf Oloruntoyin Ayipo, Halimat Yusuf Lukman, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access

4-Phenylthiazol-1,2,3-triazole derivatives as new potential α-glucosidase and α-amylase inhibitors
Mehdi Ghanbarlou, Somaye Karimian, Fatemeh Doraghi, et al.
Journal of Molecular Structure (2025), pp. 141919-141919
Closed Access

Evidence of phenolic compounds as modulators of ChREBP and NRF2 in type 2 diabetes: a review of their potential for drug development
Carina Proença, M. Graça Lobo, Ana T. Rufino, et al.
Phytochemistry Reviews (2025)
Closed Access

Dictyostelium Differentiation-Inducing Factor 1 Promotes Glucose Uptake via Direct Inhibition of Mitochondrial Malate Dehydrogenase in Mouse 3T3-L1 Cells
Yuzuru Kubohara, Yuko Fukunaga, Ayako Shigenaga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1889-1889
Open Access | Times Cited: 3

A Narrative Review: Repurposing Metformin as a Potential Therapeutic Agent for Oral Cancer
Jui-Hsiang Li, Pei-Yi Hsin, Yung-Chia Hsiao, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3017-3017
Open Access | Times Cited: 3

Comparative efficacy and safety of weekly dulaglutide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials
Hazem Ayesh, Sajida Suhail, Suhail Ayesh, et al.
Metabolism Open (2024) Vol. 22, pp. 100284-100284
Open Access | Times Cited: 1

Improving diabetic wound healing: The therapeutic potential of allulose supplement in diabetic skin tissue repair and inflammation modulation
Zheng Wang, Yuhan Shi, Pengchao Zheng, et al.
Food Bioscience (2024) Vol. 62, pp. 105439-105439
Closed Access | Times Cited: 1

Nanozymes for the Therapeutic Treatment of Diabetic Foot Ulcers
Xueqian Xiao, Fei Zhao, Davida Briana DuBois, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 7, pp. 4195-4226
Open Access

Classification, Symptoms, Treatment and Preventive Strategies of Diabetes. A guide to the basic
Magda Madoń, Patrycja Proszowska, Daria Sieniawska, et al.
Journal of Education Health and Sport (2024) Vol. 70, pp. 50192-50192
Open Access

UMA BREVE ANÁLISE FARMACOLÓGICA SOBRE O USO DE HIPOGLICEMIANTESNA POPULAÇÃO ADULTA COM DIABETES MELLITUS TIPO 2
Tiago Costa Maia, Paulo Victor Brasileiro Mota, Rodolfo Basílio Madeira Neto, et al.
Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida (2024) Vol. 16, Iss. 2
Open Access

Discovery of novel fructose-1,6-bisphosphatase inhibitors bearing benzimidazole scaffold using a dual-ligand molecular docking model
Huahao Wang, Liran Lei, Hao Guo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116888-116888
Closed Access

Iperglicemia, disturbi digestivi e calo di peso: che è successo?
Domenico Cucinotta, Nicola Silvestris, Francesco Trimarchi
L Endocrinologo (2024)
Closed Access

Evaluation of anti-diabetic effects of Glimepiride/metformin cocrystal
Xiaoli Li, Duanfang Zhou, Mingpu Liu, et al.
Journal of drug targeting (2024) Vol. 33, Iss. 3, pp. 397-409
Closed Access

Curalin supplement as add-on therapy for type 2 diabetes Mellitus
Itamar Raz, Roni Weinberg Sibony, Saar Dor, et al.
Diabetes Research and Clinical Practice (2024) Vol. 218, pp. 111912-111912
Closed Access

Page 1

Scroll to top